IATF approves booster shots for OFWs set for deployment | Inquirer News

IATF approves booster shots for OFWs set for deployment

/ 11:32 AM November 20, 2021

MANILA, Philippines — The country’s pandemic task force has approved the administration of COVID-19 booster shots for overseas Filipino workers (OFWs) who are about to be deployed within four months, vaccine czar Carlito Galvez Jr. said Saturday.

“Yes, in order to maintain our competitive advantage and also protect our OFWs and seafarers’ livelihood if boosters are being required for foreign deployment,” Galvez told INQUIRER.net in a text message when asked to confirm the decision of the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-MEID).

“We will execute this as soon as necessary since the OFW and seafarers are categorized as A1 in previous IATF Resolution,” he added.

Article continues after this advertisement

Fully-vaccinated healthcare workers started to receive booster shots on November 17. They will be followed by the elderly and people with comorbidities.

FEATURED STORIES

Meanwhile, the Department of Health earlier reminded the public that the administration of booster doses is not yet open for the general population.

It added that “the decision to offer booster doses to healthcare workers is still risk-based and its rollout to other priority groups will be implemented on a phased approach.”

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: COVID-19 Vaccine, IATF, OFWs

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.